AIM: To investigate osteopontin expression and its association with hepatopathologic changes in BALB/C mice infected with Schistosoma japonicum. METHODS: The schistosomal hepatopathologic mouse model was established by abdominal infection with schistosomal cercaria. Liver samples were obtained from mice sacrificed at 6, 8, 10, 14, and 18 wk after infection. Liver histopathological changes were observed with hematoxylin-eosin and Masson trichrome staining. The expression of osteopontin was determined with immunohistochemistry, reverse transcription-polymerase chain reaction, and Western blotting. The expression of α-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1) were determined by immunohistochemistry. Correlations of osteopontin expression with other variables (α-SMA, TGF-β1, hepatopathologic features including granuloma formation and degree of liver fibrosis) were analyzed. RESULTS: Typical schistosomal hepatopathologic changes were induced in the animals. Dynamic changes in the expression of osteopontin were observed at week 6. The expression increased, peaked at week 10 (P < 0.01), and then gradually decreased. Positive correlations between osteopontin expression and α-SMA (r = 0.720, P < 0.01), TGF-β1 (r = 0.905, P < 0.01), granuloma formation (r = 0.875, P < 0.01), and degree of liver fibrosis (r = 0.858, P < 0.01) were also observed. CONCLUSION: Osteopontin may play an important role in schistosomal hepatopathology and may promote granuloma formation and liver fibrosis through an unexplored mechanism.
AIM: To investigate osteopontin expression and its association with hepatopathologic changes in BALB/C mice infected with Schistosoma japonicum. METHODS: The schistosomal hepatopathologic mouse model was established by abdominal infection with schistosomal cercaria. Liver samples were obtained from mice sacrificed at 6, 8, 10, 14, and 18 wk after infection. Liver histopathological changes were observed with hematoxylin-eosin and Masson trichrome staining. The expression of osteopontin was determined with immunohistochemistry, reverse transcription-polymerase chain reaction, and Western blotting. The expression of α-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1) were determined by immunohistochemistry. Correlations of osteopontin expression with other variables (α-SMA, TGF-β1, hepatopathologic features including granuloma formation and degree of liver fibrosis) were analyzed. RESULTS: Typical schistosomal hepatopathologic changes were induced in the animals. Dynamic changes in the expression of osteopontin were observed at week 6. The expression increased, peaked at week 10 (P < 0.01), and then gradually decreased. Positive correlations between osteopontin expression and α-SMA (r = 0.720, P < 0.01), TGF-β1 (r = 0.905, P < 0.01), granuloma formation (r = 0.875, P < 0.01), and degree of liver fibrosis (r = 0.858, P < 0.01) were also observed. CONCLUSION:Osteopontin may play an important role in schistosomal hepatopathology and may promote granuloma formation and liver fibrosis through an unexplored mechanism.
Authors: T Niki; M Pekny; K Hellemans; P D Bleser; K V Berg; F Vaeyens; E Quartier; F Schuit; A Geerts Journal: Hepatology Date: 1999-02 Impact factor: 17.425
Authors: J N Nanas; D A Kontoyannis; G P Alexopoulos; M I Anastasiou-Nana; E P Tsagalou; S F Stamatelopoulos; S D Moulopoulos Journal: Chest Date: 2001-04 Impact factor: 9.410
Authors: Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-03-25 Impact factor: 4.052
Authors: Thiago A Pereira; Wing-Kin Syn; Mariana V Machado; Paula V Vidigal; Vivian Resende; Izabela Voieta; Guanhua Xie; Alba Otoni; Márcia M Souza; Elisângela T Santos; Isaac S Chan; Guilherme V M Trindade; Steve S Choi; Rafal P Witek; Fausto E Pereira; William E Secor; Zilton A Andrade; José Roberto Lambertucci; Anna Mae Diehl Journal: Clin Sci (Lond) Date: 2015-07-21 Impact factor: 6.124